From a virus's point of view, invading our cells is a matter of survival. The virus makes a living by highjacking cellular processes to produce more of the proteins that make it up. From our point of ...
The FDA granted priority review, with a decision expected by June 19, 2025. LEN represents a novel class of HIV therapies by targeting the viral capsid, a multifunctional protein essential for HIV ...
Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, has expanded its product offering, with the launch of the AAVX Total Capsid Quantification ...
The last time I wrote about Abeona Therapeutics (ABEO) it was in a Seeking Alpha article entitled "Abeona: BLA Resubmission of Pz-Cel Gets Ball Rolling Towards Other Milestones." With respect to this ...
A highly efficient biomaterial has been created that catalyzes the formation of hydrogen -- one half of the 'holy grail' of ...
A reduction of the retrotransposon at the Drosophila NMJ leads to a drastic increase in synaptogenesis and plasticity (-copia). The structure of Copia (center), shows a large retroviral like structure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results